Precision of digoxin radioimmunoassays and matrix effects four kits compared

https://doi.org/10.1016/S0009-9120(81)90704-9Get rights and content

We studied the interference of the sample matrix on digoxin radioimmunoassays using four commercial kits. Plasma samples from non-digitalized patients of the following categories were assayed: uncomplicated essential hypertension treated with spironolactone, uremia, and acute myocardial infarction (AMI). Digoxin 2.50 nmol/L was added to all samples. Digoxin in plasma from patients on spironolactone was overestimated by two of the kits (means 2.77 and 2.68 nmol/L, respectively; p < 0.01) and underestimated in samples from uremic patients by one kit (2.32 nmol/L; p < 0.01). The digoxin content of AMI plasma was overestimated by one kit (2.62 nmol/L; p < 0,05). Significant differences were found between radioimmunoassays when estimating digoxin concentration in the same category of patient and within individual methods used for different categories. Precision expressed as 95% confidence intervals ranged from 0.43 to 0.80 nmol/L for the kits. Thus, deviations in recorded digoxin concentrations from the true values found, but were of secondary importance because of the relatively low precision of the assays.

References (31)

  • BergdahlB. et al.

    Four kits for plasma digoxin radioimmunoassay compared

    Clin. Chem.

    (1979)
  • AnggrdE.E. et al.

    A source of error in digoxin radioimmunoassay

    N. Engl. J. Med.

    (1972)
  • BurnettG.H. et al.

    Variability of standard curves in radioimmunoassay of plasma digoxin

    Clin. Chem.

    (1973)
  • Bertler. et al.
  • HuffmanD.H.

    The effect of spironolactone and canrenone on the digoxin radioimmunoassay

    Res. Commun. Chem. Pathol. Pharmacol.

    (1974)
  • Cited by (0)

    View full text